Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis

This study has been completed.
Information provided by Office of Rare Diseases (ORD)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00004814

Sponsors and Collaborators

Investigators